IGF1R and esophageal cancer: Tang and colleagues demonstrated the antiproliferative activity of biguanide also in esophageal cancer cells, mediated partly by the suppressed expression of the insulin-like growth factor 1 receptor (IGF-1R) and its downstream targets PI3K, AKT, mTOR, p70S65, and PKM2 [84].